Fetal Growth Restriction
40
8
9
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
2 terminated out of 40 trials
86.7%
+0.2% vs benchmark
18%
7 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (40)
The Combined First Trimester Screening
Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR
AI-POCUS for Maternal and Neonatal Health in Ethiopia
Maternal Left Lateral Position in Fetal Growth Restriction
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
Study of Placental Vascularization Using Contrast Ultrasound
Prostaglandins Versus Trans-cervical Balloon for Induction of Labor in Fetal Growth Restriction (PROBIN)
USCOM in Newly Diagnosed FGR Cases
Pregnancy in GUCH Patients
Expanded NIPT for Pregnancy Complications
Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach
Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
Evaluation of HALP Score in Distinction Between FGR and SGA
COmputerized CTG Self-MOnitoring Versus Standard Doppler Assessment in Late-onset FGR: COSMOS Study
Speckle Tracking Echocardiography in Infants, Prenatally and Postnatally
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Evaluation of the Safety and Performance of Centaflow
Fetal Distribution of Feto-placental Blood Flow Related to Placental Nutrient Transport and Maternal Food Intake
Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening